Texas (July 23, 2013) Wax Ink has issued an Initial of Investment Interest rating for Celestica, Inc. (NYSE: CLS) based on a recent baseline equity review which placed fair value between $29-$32.
The recent close of $9.32 is approximately 46% below the fair value buy target for the stock and approximately 74% below the fair value close target for the stock. The recent close is also 4% above analysts' twelve-month $9.00 median price target for the stock.
The recent close represents a 26% increase in price since the last baseline equity review was conducted in July of 2012.
The stock currently has a trailing twelve-month PE Ratio of 8, and a PEG Ratio of 0.6 basis estimated forward earnings growth of 13%.
In the past 52 weeks, share prices have moved between a high of $9.98 and a low of $6.64, placing equilibrium at $8.76.
Basis the recent close, the stock is trading 7% below the 52 week high, 29% above the 52 week low, 6% above equilibrium, and has an average daily trading volume of approximately 196,000 shares.
Celestica, Inc. provides supply chain solutions to original equipment manufacturers and service providers in the communications, consumer, enterprise computing, industrial, aerospace and defense, healthcare, green technology, semiconductor equipment, and other end markets in the Americas, Asia, and Europe.
The company's competitors include Benchmark Electronics, Inc., Flextronics International Ltd., Jabil Circuit, Inc., Sanmina Corporation, and Plexus Corporation.
Financial information that may be contained herein, is based on the company's most recent annual SEC filing for year ending December 31, 2012. All prices are per share unless otherwise noted.
Wax Ink currently has no investment position in the company mentioned in this alert.
For use by Accredited Investors as defined under Title 17, CFR §230.500, Regulation D
Wax Ink is a baseline equity research company NOT licensed or registered with any government agency
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.